To amend the Internal Revenue Code of 1986 to provide a tax credit to health care professionals that provide health care services in qualifying facilities, and for other purposes.

What happened: On March 9, 2026, Rep. Tenney (R-NY) introduced HR7884, the 'Healthcare is Human Act of 2026,' which was immediately referred to the House Committee on Ways and Means. The bill proposes a tax credit of $300-$500 per month for licensed healthcare professionals who provide qualifying services in facilities that accept Medicare or Medicaid, contingent on providing between 80 and over 160 hours of service monthly. With only one cosponsor (Rep. Horsford, D-NV) and zero committee markups or hearings, this is a low-priority bill in the 119th Congress with minimal legislative momentum. The bill is at the earliest possible stage — introduction — and faces the full committee and floor passage gauntlet in the House, then Senate introduction and passage, before any presidential action.

The money trail: There is NO appropriation in this bill. The tax credit is a revenue-side provision that reduces federal tax receipts; it does not allocate new spending. If enacted, the credit would be claimed on individual tax returns by qualifying health professionals, reducing their tax liability by up to $6,000 annually ($500×12 months max). The Joint Committee on Taxation has not yet scored this bill (no CBO or JCT report published). There is no funding authorization, no grant program, and no direct federal spending. This is a pure tax expenditure mechanism that would reduce Treasury revenue, not distribute appropriated dollars. The bill's impact on healthcare company revenues is structural rather than direct: if the credit increases clinician hours in Medicare/Medicaid settings, hospitals and clinics could see higher service volume, but the effect is contingent on clinician response to a relatively small monthly incentive ($300-$500) and the bill's passage probability is near-zero at this stage.

Structural winners and losers: No specific publicly traded companies are directly named or affected by this bill. The credit targets individual clinicians, not corporations. Hospitals and healthcare facilities could indirectly benefit from improved staffing in qualifying facilities (defined as those accepting Medicare/Medicaid), which includes for-profit hospital chains like HCA Healthcare ($HCA), Community Health Systems ($CYH), and Tenet Healthcare ($THC), as well as managed care organizations like UnitedHealth Group ($UNH), Humana ($HUM), and CVS Health ($CVS) that operate Medicare Advantage plans. However, the credit is too small ($300-$500/month) to materially shift clinician labor supply or hospital operating margins. No tickers meet the causal chain gate (Rule 17) because the bill does not mandate, incentivize, or penalize any publicly traded company directly — it targets individual tax filers.

Real market data context: $CVS trades at $83.12, up 15.73% in 30 days and approaching its 52-week high of $85.15. $HUM trades at $242.44, up 39.82% in 30 days from $205.14 on April 17. This health sector rally is broad and driven by factors unrelated to HR7884: likely Medicare Advantage rate announcements, earnings season results, or broader market rotation. The bill was introduced March 9 and has seen zero subsequent legislative action; the stock moves in April are decoupled from this legislation.

Timeline: The bill has no scheduled markup, no Senate companion, and no CBO score. For it to become law, it must pass Ways and Means, pass the full House, be introduced and passed in the Senate (where a different version may emerge), go to conference committee, and be signed by the President. Given the late stage of the 119th Congress (2026 is an election year) and the bill's status, passage probability is minimal. No actionable timeline exists.